Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study.

Poo, Jorge Luis

Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. [electronic resource] - Journal of gastroenterology and hepatology Dec 2004 - S79-81 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

1440-1746

10.1111/j.1440-1746.2004.03634.x doi


Adult
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Female
Hepacivirus--drug effects
Hepatitis C, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Male
Mexico
Middle Aged
Pilot Projects
Polyethylene Glycols--therapeutic use
RNA, Viral--blood
Recombinant Proteins
Ribavirin--therapeutic use
Thymalfasin
Thymosin--analogs & derivatives
Time Factors
Treatment Failure
Treatment Outcome
Viral Load
Virus Replication--drug effects